Outset Medical Names Business Leader Dale E. Jones to Board of Directors
25 Avril 2022 - 10:00PM
Business Wire
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical
technology company reducing the cost and complexity of dialysis,
today announced the appointment of Dale E. Jones to its Board of
Directors.
“Dale brings more than 30 years of experience in building
diverse and dynamic teams to Outset at a time of exceptional growth
for our team,” said Chair and CEO Leslie Trigg. “He leads with
purpose and deeply understands the role values and culture play in
building high-performance organizations, critical traits as we
focus on transforming dialysis.”
Mr. Jones is a Senior Advisor at Diversified Search Group, and
previously served as its CEO for more than eight years. He began
his career in banking, before moving into executive search as a
managing partner in the Atlanta office of Heidrick & Struggles
International in 1999. In 2007, he relocated to Washington, D.C. to
lead a philanthropic initiative, endowed by AOL founder Steve Case
and his wife, Jean, that was dedicated to providing access to clean
water in Africa. Mr. Jones returned to executive search in 2009,
rejoining Heidrick & Struggles to serve as Vice Chairman and
Partner of the CEO and Board Practice, where he consulted CEOs and
corporate boards on human capital issues including recruiting,
retention, succession planning, and corporate governance.
“I am inspired by the work Outset Medical is doing to improve
the lives of dialysis patients and look forward to contributing to
its continued growth,” said Mr. Jones. “The company has
demonstrated an impressive track record of building an exceptional
organization, attracting top talent and, importantly, delivering
exceptional results.”
Mr. Jones serves on the boards of Northwestern Mutual, The
Special Olympics, Chick-fil-A, and his alma mater, Morehouse
College. He has been appointed to the compensation committee of the
Outset Board.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a
first-of-its-kind technology to reduce the cost and complexity of
dialysis. The Tablo Hemodialysis System, FDA-cleared for use from
the hospital to the home, represents a significant technological
advancement that transforms the dialysis experience for patients
and operationally simplifies it for providers. Tablo serves as a
single enterprise solution that can be utilized across the
continuum of care, allowing dialysis to be delivered anytime,
anywhere and by anyone. The integration of water purification and
on-demand dialysate production enables Tablo to serve as a dialysis
clinic on wheels, with 2-way wireless data transmission and a
proprietary data analytics platform powering a new holistic
approach to dialysis care. Tablo is a registered trademark of
Outset Medical, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220425005711/en/
Investor Contact Jim Mazzola jmazzola@outsetmedical.com
Media Contact Nicole Shannon Director, Marketing
Communications for Outset Medical nshannon@outsetmedical.com
Grupo Aeroportuario del ... (NASDAQ:OMAB)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Grupo Aeroportuario del ... (NASDAQ:OMAB)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
